首页> 美国卫生研究院文献>Evidence-based Complementary and Alternative Medicine : eCAM >Lead Screening for Chronic Obstructive Pulmonary Disease of IKK2 Inhibited by Traditional Chinese Medicine
【2h】

Lead Screening for Chronic Obstructive Pulmonary Disease of IKK2 Inhibited by Traditional Chinese Medicine

机译:中药抑制IKK2慢性阻塞性肺疾病的铅筛选

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Chronic obstructive pulmonary disease (COPD) is a chronic obstructive lung disease and is frequently found in well-developed countries due to the issue of aging populations. Not all forms of medical treatment are unable to return a patient's limited pulmonary function back to normal and eventually they could require a lung transplant. At this time, COPD is the leading cause of death in the world. Studies surveying I-kappa-B-kinase beta (IKK2) are very relevant to the occurrence and deterioration of the condition COPD. The sinapic acid-4-O-sulfate, kaempferol, and alpha-terpineol were found to be IKK2 inhibitors and helped prevent COPD occurrence and worsening according to a screening of the traditional Chinese medicine (TCM) database. The protein-ligand interaction of these three compounds with regard to IKK2 was also done by molecular dynamics. The docking poses, hydrogen bond variation, and hydrophobic interactions found Asp103 and Lys106 are crucial to IKK2 binding areas for IKK2 inhibition. Finally, we found the three compounds that have an equally strong effect in terms of IKK2 binding proven by the TCM database and perhaps these may be an alternative treatment for COPD in the future.
机译:慢性阻塞性肺疾病(COPD)是一种慢性阻塞性肺疾病,由于人口老龄化问题,在发达的国家经常发现。并非所有形式的药物治疗都无法使患者有限的肺功能恢复正常,最终可能需要进行肺移植。目前,COPD是世界上主要的死亡原因。研究I-κB激酶β(IKK2)的研究与COPD病情的发生和恶化非常相关。根据对传统中药(TCM)数据库的筛选,发现芥子酸4-O-硫酸盐,山奈酚和α-萜品醇是IKK2抑制剂,有助于预防COPD发生和恶化。这三种化合物相对于IKK2的蛋白质-配体相互作用也通过分子动力学完成。发现Asp103和Lys106的对接姿势,氢键变化和疏水相互作用对抑制IKK2的IKK2结合区域至关重要。最后,我们发现这三种化合物在中药数据库中证实的IKK2结合方面具有同等强大的作用,也许将来它们可能成为COPD的替代疗法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号